SCAN-2030 aims to establish a HTA ecosystem in Hong Kong, enhancing the access, delivery, and introduction of innovative and cost-effective medications. By implementing an evidence-based evaluation system, we provide a pipeline of global medicines (Horizon Scanning) and develop prioritization criteria (HTA) to ensure healthcare system preparedness.